Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217834 · ClinicalTrials.gov registry record · NA
Effects of a Glycerol-Electrolyte Beverage on Fluid Balance in Healthy Euhydrated Men and Women
A NA study of Fluid Balance, sponsored by PepsiCo Global R&D.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07217834 is a NA study of Fluid Balance that is actively recruiting participants, run by PepsiCo Global R&D. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07217834, a NA study of Fluid Balance, is actively recruiting participants, sponsored by PepsiCo Global R&D.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Glycerol and sodium are osmotically-active ingredients that promote fluid retention via renal water reabsorption. The purpose of this study is to compare the effects of a glycerol-electrolyte beverage on fluid balance in healthy euhydrated men and women
Conditions Studied
Interventions
- OTHER Placebo beverage, kiwi-strawberry flavor
- OTHER Experimental glycerol beverage, kiwi-strawberry flavor
Study Locations (1)
Florida
- IMG Academy/GSSI Bradenton Gatorade Sports Science Institute - Bradenton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2025-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07217834
The ClinicalTrials.gov registry entry for NCT07217834 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PepsiCo Global R&D, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fluid Balance appearing as the primary indexed condition, and to 2 interventions - of which Placebo beverage, kiwi-strawberry flavor is the first listed.
NCT07217834 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07217834 about?
NCT07217834 is a clinical study titled "Effects of a Glycerol-Electrolyte Beverage on Fluid Balance in Healthy Euhydrated Men and Women". Glycerol and sodium are osmotically-active ingredients that promote fluid retention via renal water reabsorption. The purpose of this study is to compare the effects of a glycerol-electrolyte beverage on fluid balance in healthy euhydrated men and women
What is the current status of trial NCT07217834?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-10-01. Estimated completion is 2025-12-12.
What conditions does trial NCT07217834 study?
This clinical trial studies the following conditions: Fluid Balance.
What interventions are being tested in trial NCT07217834?
The interventions under investigation include: Placebo beverage, kiwi-strawberry flavor (OTHER), Experimental glycerol beverage, kiwi-strawberry flavor (OTHER).
Who is sponsoring clinical trial NCT07217834?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07217834 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fluid Balance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.